Sign up to save your podcasts
Or
Share A BET on a Novel Approach to Treat Autoimmune Conditions
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A BET on a Novel Approach to Treat Autoimmune Conditions
The BET family of proteins regulates gene expression. Their overexpression has been implicated in both cancer and inflammatory diseases. Vyne Therapeutics is developing oral and topical BET inhibitors that treat inflammatory conditions ranging from rheumatoid arthritis to the skin condition vitiligo. We spoke to Vyne CEO David Domzalski and Vyne Chief Scientific Officer Iain Stuart, about the role BET plays in autoimmune diseases, its platform technology, and its efforts to develop BET inhibitors that are both potent and specific.
View all episodes
By Levine Media Group
3.7
3939 ratings
The BET family of proteins regulates gene expression. Their overexpression has been implicated in both cancer and inflammatory diseases. Vyne Therapeutics is developing oral and topical BET inhibitors that treat inflammatory conditions ranging from rheumatoid arthritis to the skin condition vitiligo. We spoke to Vyne CEO David Domzalski and Vyne Chief Scientific Officer Iain Stuart, about the role BET plays in autoimmune diseases, its platform technology, and its efforts to develop BET inhibitors that are both potent and specific.
More shows like The Bio Report
View all
Economist Podcasts
4,146 Listeners
WSJ Your Money Briefing
1,707 Listeners
We Study Billionaires - The Investor’s Podcast Network
3,372 Listeners
Masters in Business
2,170 Listeners
Bold Names
1,445 Listeners
The Indicator from Planet Money
9,539 Listeners
The Readout Loud
321 Listeners
Interesting Times with Ross Douthat
7,219 Listeners
The Journal.
6,066 Listeners
BioCentury This Week
34 Listeners
Dwarkesh Podcast
518 Listeners
Hard Fork
5,526 Listeners
Biotech Hangout
20 Listeners
Ground Truths
50 Listeners
Money Stuff: The Podcast
393 Listeners